Shu-chen Lu

2 Patents

• US124656522025

  Method of Treating or Ameliorating Metabolic Disorders Using Antagonistic Binding Proteins for Gastric Inhibitory Peptide Receptor (GIPR)/GLP-1 Receptor Agonist Fusion Proteins

  AMGEN Inc.

  0 cites
• US122140512025

  Method of Treating or Ameliorating Metabolic Disorders Using GLP-1 Receptor Agonists Conjugated to Antagonists for Gastric Inhibitory Peptide Receptor (GIPR)

  Amgen Inc.

  0 cites